13YRSKaifeng Red Maple Leaf Biotechnology Co., Ltd.

Обзор компании

Альбом компании3

Основная информация
Kaifeng Red Maple Leaf Biotechnology Co., Ltd. was founded in 2004. Our company is located in Kaifeng, Henan, China, covering an area of 26 thousand square meters with 287 employees. Being in the leading position in the industry, we have 5 modern advanced production lines, including 3 production lines of soft capsules and 2 production lines of tablets. Our company is a modernized high-tech enterprise dedicated to biological technology research, development, manufacture and marketing. We have achieved HACCP, ISO18000, ISO14000, and GMP certificates, and gained Health Product Manufacturing License of Enterprise and Food Hygiene License of Enterprise.Red Maple Leaf Biotechnology has a elite team and high-quality talents with ability of research and development for advanced technology. We have a detection and experiment center and highly sophisticated and high precision testing instruments. The high-quality products produced by Red Maple Leaf have been sold throughout the 32 provinces and regions in China and been exported to Europe, the Middle East and South Asia. Our products have important position in the international market. Our constant running idea is to strive for excellence and be in pursuit for perfection.
4.7/5
Довольны
6 Reviews
  • 32 Транзакции
    40,000+
  • Время отклика
    ≤5h
  • Частота откликов
    97.05%
Тип компании
Производитель, Торговая компания
Страна / Регион
Henan, China
Основные продуктыВсего сотрудников
201 - 300 People
Общий годовой доход
Below US$1 Million
Год основания
2004
Сертификаты
-
Сертификаты на продукцию
-
Патенты
-
Товарные знаки
-
Основные рынки

Емкость продукта

Информация о заводе

Размер завода
10,000-30,000 square meters
Местоположение завода
No.6 310 State Road Industrial Park Of Gulou District Kaifeng City,Henan Province,China
Число производственных линий
Above 10
Контрактное производство
OEM Service Offered, Design Service Offered, Buyer Label Offered
Годовой выпуск
US$5 Million - US$10 Million

R&D возможности

Исследования и разработки

11 - 20 People